329 related articles for article (PubMed ID: 29662486)
1. Mucosal Involvement in Bullous Pemphigoid Is Mostly Associated with Disease Severity and to Absence of Anti-BP230 Autoantibody.
Clapé A; Muller C; Gatouillat G; Le Jan S; Barbe C; Pham BN; Antonicelli F; Bernard P
Front Immunol; 2018; 9():479. PubMed ID: 29662486
[TBL] [Abstract][Full Text] [Related]
2. BPDAI and ABSIS correlate with serum anti-BP180 NC16A IgG but not with anti-BP230 IgG in patients with bullous pemphigoid.
Daneshpazhooh M; Ghiasi M; Lajevardi V; Nasiri N; Balighi K; Teimourpour A; Khosravi H; Saeidi V; Mahmoudi H; Chams-Davatchi C
Arch Dermatol Res; 2018 Apr; 310(3):255-259. PubMed ID: 29423547
[TBL] [Abstract][Full Text] [Related]
3. IgE anti-BP180 NC16A autoantibody in both serum and blister fluid samples does not correlate with disease activity of bullous pemphigoid.
Sun C; Qian H; Liang G; Xiang R; Zhao C; Li Z; Suo L; Jing K; Wang Y; Zhang H; Li X; Feng S
Eur J Dermatol; 2023 Dec; 33(6):595-603. PubMed ID: 38465539
[TBL] [Abstract][Full Text] [Related]
4. Correlation of Serum Levels of IgE Autoantibodies Against BP180 With Bullous Pemphigoid Disease Activity.
van Beek N; Lüttmann N; Huebner F; Recke A; Karl I; Schulze FS; Zillikens D; Schmidt E
JAMA Dermatol; 2017 Jan; 153(1):30-38. PubMed ID: 27829102
[TBL] [Abstract][Full Text] [Related]
5. Basement membrane zone IgE deposition is associated with bullous pemphigoid disease severity and treatment results.
Kamata A; Kurihara Y; Funakoshi T; Takahashi H; Kuroda K; Hachiya T; Amagai M; Yamagami J
Br J Dermatol; 2020 May; 182(5):1221-1227. PubMed ID: 31330562
[TBL] [Abstract][Full Text] [Related]
6. Association of autoantibodies to BP180 with disease activity in Greek patients with bullous pemphigoid.
Patsatsi A; Kyriakou A; Pavlitou-Tsiontsi A; Giannakou A; Sotiriadis D
Clin Dev Immunol; 2012; 2012():854795. PubMed ID: 23227089
[TBL] [Abstract][Full Text] [Related]
7. More Severe Erosive Phenotype Despite Lower Circulating Autoantibody Levels in Dipeptidyl Peptidase-4 Inhibitor (DPP4i)-Associated Bullous Pemphigoid: A Retrospective Cohort Study.
Ständer S; Schmidt E; Zillikens D; Ludwig RJ; Kridin K
Am J Clin Dermatol; 2021 Jan; 22(1):117-127. PubMed ID: 33026629
[TBL] [Abstract][Full Text] [Related]
8. International validation of the Bullous Pemphigoid Disease Area Index severity score and calculation of cut-off values for defining mild, moderate and severe types of bullous pemphigoid.
Masmoudi W; Vaillant M; Vassileva S; Patsatsi A; Quereux G; Moltrasio C; Abasq C; Prost-Squarcioni C; Kottler D; Kiritsi D; Litrowski N; Plantin P; Friedrichsen L; Zebrowska A; Duvert-Lehembre S; Hofmann S; Ferranti V; Jouen F; Joly P; Hebert V;
Br J Dermatol; 2021 Jun; 184(6):1106-1112. PubMed ID: 33067805
[TBL] [Abstract][Full Text] [Related]
9. Assessment of bullous pemphigoid disease area index during treatment: a prospective study of 30 patients.
Lévy-Sitbon C; Barbe C; Plee J; Goeldel AL; Antonicelli F; Reguiaï Z; Jolly D; Grange F; Bernard P
Dermatology; 2014; 229(2):116-22. PubMed ID: 25011586
[TBL] [Abstract][Full Text] [Related]
10. Clinical manifestations in 100 Japanese bullous pemphigoid cases in relation to autoantigen profiles.
Tanaka M; Hashimoto T; Dykes PJ; Nishikawa T
Clin Exp Dermatol; 1996 Jan; 21(1):23-7. PubMed ID: 8689764
[TBL] [Abstract][Full Text] [Related]
11. Serum levels of IgE anti-BP180 and anti-BP230 autoantibodies in patients with bullous pemphigoid.
Ishiura N; Fujimoto M; Watanabe R; Nakashima H; Kuwano Y; Yazawa N; Echigo T; Okochi H; Tamaki K
J Dermatol Sci; 2008 Feb; 49(2):153-61. PubMed ID: 17920818
[TBL] [Abstract][Full Text] [Related]
12. Levels of anti-BP180 NC16A IgE do not correlate with severity of disease in the early stages of bullous pemphigoid.
Bing L; Xiping Z; Li L; Jun P; Yi-Xia W; Min Y; Qing L; Qiu-Ning S; Hong-Zhong J; Ya-Gang Z
Arch Dermatol Res; 2015 Nov; 307(9):849-54. PubMed ID: 26404084
[TBL] [Abstract][Full Text] [Related]
13. Detection of IgE autoantibodies to BP180 and BP230 and their relationship to clinical features in bullous pemphigoid.
Hashimoto T; Ohzono A; Teye K; Numata S; Hiroyasu S; Tsuruta D; Hachiya T; Kuroda K; Hashiguchi M; Kawakami T; Ishii N
Br J Dermatol; 2017 Jul; 177(1):141-151. PubMed ID: 27716903
[TBL] [Abstract][Full Text] [Related]
14. Autoreactive Peripheral Blood T Helper Cell Responses in Bullous Pemphigoid and Elderly Patients With Pruritic Disorders.
Didona D; Scarsella L; Fehresti M; Solimani F; Juratli HA; Göbel M; Mühlenbein S; Holiangu L; Pieper J; Korff V; Schmidt T; Sitaru C; Eming R; Hertl M; Pollmann R
Front Immunol; 2021; 12():569287. PubMed ID: 33841390
[TBL] [Abstract][Full Text] [Related]
15. Role of BP230 autoantibodies in bullous pemphigoid.
Shih YC; Wang B; Yuan H; Zheng J; Pan M
J Dermatol; 2020 Apr; 47(4):317-326. PubMed ID: 32048350
[TBL] [Abstract][Full Text] [Related]
16. Usefulness of BP230 and BP180-NC16a enzyme-linked immunosorbent assays in the initial diagnosis of bullous pemphigoid: a retrospective study of 138 patients.
Charneux J; Lorin J; Vitry F; Antonicelli F; Reguiai Z; Barbe C; Tabary T; Grange F; Bernard P
Arch Dermatol; 2011 Mar; 147(3):286-91. PubMed ID: 21422334
[TBL] [Abstract][Full Text] [Related]
17. Anti-Type VII Collagen Antibodies Are Identified in a Subpopulation of Bullous Pemphigoid Patients With Relapse.
Giusti D; Gatouillat G; Le Jan S; Plée J; Bernard P; Antonicelli F; Pham BN
Front Immunol; 2018; 9():570. PubMed ID: 29619029
[TBL] [Abstract][Full Text] [Related]
18. Characteristics of IgG subclasses and complement deposition in BP230-type bullous pemphigoid.
Zheng M; Ujiie H; Iwata H; Muramatsu K; Yoshimoto N; Ito T; Ujiie I; Shimizu S; Sato-Matsumura KC; Shimizu H
J Eur Acad Dermatol Venereol; 2019 Mar; 33(3):595-600. PubMed ID: 30394605
[TBL] [Abstract][Full Text] [Related]
19. Bullous pemphigoid (BP) patients with selective IgG autoreactivity against BP230: Review of a rare but valuable cohort with impact on the comprehension of the pathogenesis of BP.
Ramcke T; Vicari E; Bolduan V; Enk A; Hadaschik E
J Dermatol Sci; 2022 Feb; 105(2):72-79. PubMed ID: 34930674
[TBL] [Abstract][Full Text] [Related]
20. Anti-BP180 and anti-BP230 enzyme-linked immunosorbent assays for diagnosis and disease activity tracking of bullous pemphigoid: A prospective cohort study.
Chanprapaph K; Ounsakul V; Pruettivorawongse D; Thadanipon K
Asian Pac J Allergy Immunol; 2021 Dec; 39(4):272-278. PubMed ID: 31175713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
